-
Inflammatory Bowel Disease (IBD) Drugs Market Projected to Reach USD 27.65 Billion by 2031
24 Apr 2024 14:22 GMT
IBD Drugs Market is experiencing steady growth, driven by the increasing prevalence of IBD conditions and the demand for effective treatment options
AUSTIN, TEXAS, UNITED STATES, April 24, 2024 /EINPresswire.com/ -- According to a report by SNS …
-
Takeda gets USFDA nod for Entyvio subcutaneous administration for Crohn's disease
21 Apr 2024 07:58 GMT
Osaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn’s disease (CD) after induction …
-
Takeda's vedolizumab receives US FDA approval to treat moderately to severely active Crohn's disease
20 Apr 2024 10:39 GMT
Takeda announced that the US FDA has approved Entyvio (vedolizumab) subcutaneous administration for maintenance therapy in adults with moderately to severely active Crohn’s disease (CD) after induction therapy with intravenous (IV) Entyvio. The …
-
Louise Thompson reveals the clothes she won't wear with her stoma bag and shares what she has named it
25 Apr 2024 00:09 GMT
Louise Thompson has proudly revealed there is 'nothing' she won't wear after getting a stoma bag fitted.
The former Made In Chelsea star, 34, revealed earlier this month she had a stoma bag fitted after years of suffering from ulcerative …
-
Roivant Sciences: Cashing In On Vants And Ventures
24 Apr 2024 20:16 GMT
We AreRoivant Sciences: Strategic Moves and Diverse Pipeline Roivant Sciences (NASDAQ:ROIV) is down nearly 5% since my last update in September. Back then, I highlighted the company's strong balance sheet and opportunity in dermatology. Roivant has …
-
VELSIPITY Receives Health Canada Approval for Adults with Moderately to Severely Active Ulcerative Colitis (UC)
24 Apr 2024 18:39 GMT
VELSIPITY is a once-daily, oral, sphingosine 1-phosphate (S1P) receptor modulator that selectively binds with S1P receptor subtypes 1, 4, and 5.
KIRKLAND, QC, April 24, 2024 /CNW/ - Today, Pfizer Canada announced that Health Canada has granted a …
-
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
24 Apr 2024 13:40 GMT
The Good Brigade | Digitalvision | Getty Images
Health care, long an ailing stock market sector, has recovered over the past six months, with currently robust vital signs and strong growth projections.
The recovery comes after the sector failed to make …
-
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
24 Apr 2024 12:47 GMT
First patient enrolled in the global, 300-patient, Phase 2 adaptive platform trial arm of RHB-107 (upamostat)1 for early COVID-19 outpatient treatment, funded through non-dilutive external sources, including the U.S. Department of Defense
The study is …
-
Are Direct-to-Consumer Microbiome Tests Clinically Useful?
24 Apr 2024 12:25 GMT
Companies selling gut microbiome tests directly to consumers offer up a variety of claims to promote their products.
"We analyze the trillions of microbes in your gut microflora and craft a unique formula for your unique gut needs," one says. …
-
Is medical marijuana legal in SC? What to know about Bill S423
24 Apr 2024 10:12 GMT
The unofficial 420 holiday passed just a few days ago, bringing attention to the fact that South Carolina is one of the states that has yet to legalize marijuana usage.
In the U.S., marijuana use is legal across 24 states, according to the Pew Research …